Background One Brave Idea aims to identify coronary heart disease at its earliest stages of development through identifying new biological pathway(s) and creating new prevention strategies, generalizable lessons in phenotyping, and new approaches to diagnostics and stratification for coronary heart disease. Food is critical in the development and prevention of coronary heart disease, yet previous research has been limited in scale and scope and has relied upon methods that are prone to bias. FoodSwitch will be transformative because it will provide a scalable research platform to: 1) define the packaged food-ome on a global scale, 2) conduct behavioral and nutrition assessment research, including randomized trials of individuals with coronary heart disease phenotypes and precursors, and that will be 3) linked to electronic health record data for patient-reported and clinical outcomes. This project adds value to the One Brave Idea program by coalescing population, behavioral, nutrition, biological, and clinical trial research into a single, scalable platform to help achieve the program’s aims. Aim 1: Create a comprehensive, transformative, real-time surveillance system of the packaged food supply in FoodSwitch by coupling existing branded food composition data with crowdsourcing to help define the food-ome.
|Effective start/end date||4/1/18 → 12/31/21|
- Brigham and Women’s Hospital (BWH #116347 // BWH #116347)
- American Heart Association (BWH #116347 // BWH #116347)
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.